Name: Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (en Inglés)
SKU: 58991176
Price: 2654.88 MXN
Availability: InStock
Author: Maurício, Ana Colette
ISBN: 9789535128656

portada Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (en Inglés)

Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (en Inglés)

Formato

Libro Físico

Editorial

Intechopen

Autor

Maurício, Ana Colette

Idioma

Inglés

N° páginas

260

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.6 cm

Peso

0.61 kg.

ISBN13

9789535128656

Categorías

Biología celular (citología)

Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (en Inglés)

Maurício, Ana Colette (Autor) · Intechopen · Tapa Dura

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 4,424.81$ 2,654.88

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 2,654.88

¡Envío Gratis! Llega entre el 15 Oct y el 23 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (en Inglés)"

Umbilical cord blood (UCB) and, more recently, umbilical cord tissue (UCT) have been stored cryopreserved in private and public cord blood and tissue banks worldwide, since the umbilical cord blood was used for the first time in a child with Fanconi anemia with his HLA-identical sibling, following strict guidelines that imply high-quality standards and total rastreability of these units. The hematopoietic stem cells (HSCs) are clinically used in hematopoietic treatments for blood disorders and hemato-oncological diseases. Also, the mesenchymal stem cells (MSCs) isolated from the UCT and UCB, nowadays, can be used as coadjuvants of hematopoietic transplants. In the near future, these stem cells will have a crucial role in regenerative medicine. For this reason, these cells have been tested in several clinical trials and compassive treatments in children and adults, concerning a wide range of pathologies and diseases, for instance, for the treatment of cerebral paralysis. Considering the worldwide availability of UCB and UCT units and the absence of ethical concerns will probably become the best sources for cell-based therapies for hematological and nonhematological pathologies. The UCB will also have a crucial role in neonatology-predictive analysis in the near future.